US Stock MarketDetailed Quotes

IVA Inventiva

Watchlist
  • 3.080
  • +0.170+5.84%
Close Feb 25 16:00 ET
  • 3.080
  • 0.0000.00%
Post 19:09 ET
292.45MMarket Cap-1.42P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Feb 20 15:00
    NEWS
    $Inventiva (IVA.US)$
    Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
    Thursday, 20th February at 4:00 pm
    • Initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 study
    • Positive results could support the initiation of a pivotal Phase 3 trial in patients in Japan with MASH
    • The study represents...
    Jaguar8
    Jaguar8
    Jan 29 15:00
    NEWS
    $Inventiva (IVA.US)$
    Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology
    Wednesday, 29th January at 4:00 pm
    • As previously reported1, the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of t...
    Jaguar8
    Jaguar8
    Jan 22 23:28
    🟤 Watchlist, JANUARY 23,2025, Thursday. NFA
    NOTE!
    1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
    2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
    3. Scale out and secure profits.
    4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
    5. I DO NOT give buy or sell advice
    6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
    7. NEVER be a blind follower.
    8. With regards t...
    17
    9
    Jaguar8
    Jaguar8
    Jan 22 15:00
    NEWS
    $Inventiva (IVA.US)$
    Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
    Wednesday, 22nd January at 4:00 pm
    Daix (France), New York City (New York, United States), January 22, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfu...
    Jaguar8
    Jaguar8
    Dec 16, 2024 01:31
    NEWS
    $Inventiva (IVA.US)$
    Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million
    Monday, 16th December at 2:30 am
    ◦ Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024.
     
    ◦ Proceeds from the completed first tranche to be primarily used to advance Inventiva's ...
    1
Read more
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Hutchmed (China)
HCM
+2.21%
Enerpac Tool
EPAC
+2.10%
Ermenegildo Zegna NV
ZGN
+1.63%
Lantheus
LNTH
+1.39%
eBay
EBAY
+1.34%

Unlock the Full List